Nancy Lynn Kuntz MD

Child Neurology•Chicago, IL

Associate Professor in Pediatrics and Neurology, Northwestern University Medical School

Join to View Full Profile

225 E. Chicago AveBox 51Chicago, IL 60611
Phone+1 507-284-2511

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Child Neurology, 1977 - 1980
Johns Hopkins UniversityResidency, Pediatrics, 1975 - 1977
Boston University School of MedicineClass of 1975

Certifications & Licensure

IL State Medical License 2009 - 2026
HI State Medical License 1986 - 2024
WI State Medical License 2003 - 2011
MN State Medical License 1999 - 2010
American Board of Pediatrics Pediatrics
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD) Start of enrollment: 2005 Dec 01
Unknown status
Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies Start of enrollment: 2010 Feb 01
Completed
Phase 2, Phase 3
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping Start of enrollment: 2012 Apr 01
Unknown status
Finding the Optimum Regimen for Duchenne Muscular Dystrophy Start of enrollment: 2013 Jan 01
Completed
Phase 3
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping Start of enrollment: 2012 Sep 01
Unknown status
A Study of Tadalafil for Duchenne Muscular Dystrophy Start of enrollment: 2013 Sep 01
Terminated
Phase 3
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy Start of enrollment: 2014 Apr 17
Completed
Phase 2
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy Start of enrollment: 2014 Aug 19
Terminated
Phase 3
A Medical Chart Review of Patients With X-Linked Myotubular Myopathy (XLMTM) Start of enrollment: 2014 Sep 01
Completed
Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients Start of enrollment: 2015 Oct 08
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

Prevalence of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in Individuals With Dystrophinopathy at a Tertiary Care Center in Chicago.
Emily Diehl, Meghan O'Neill, Larry Gray, Abigail Schwaede, Nancy Kuntz
Pediatric Neurology. 2024-09-01
5 citations
Spinal Muscular Atrophy Update in Best Practices: Recommendations for Diagnosis Considerations.
Mary Schroth, Jennifer Deans, Kapil Arya, Diana Castro, Darryl C De Vivo
Neurology. Clinical Practice. 2024-08-01
8 citations
Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy: A Randomized Controlled Trial.
Utkarsh J Dang, Jesse M Damsker, Michela Guglieri, Paula R Clemens, Seth J Perlman
Neurology. 2024-03-12

Press Mentions

Novel Drug May Improve Treatment for Duchenne Muscular DystrophyNovember 9th, 2020
SMA Economic, QoL Burden High in Pre-Treatment EraJune 12th, 2020
Breakthrough Drug Offers Hope for Patients with Debilitating Muscular DiseaseDecember 7th, 2017
Join now to see all